Latest Articles

Webinar: CBD for Anxiety & Depression--Case Studies & Clinical Pearls

By Erik Goldman

CV Sci Shunney Webinar

 

VIEW WEBINAR

Information about CBD (cannibidiol) and the endocannabinoid system is everywhere these days. So are claims about the health benefits of CBD. As compelling as these topics may be, the information presented is rarely clinically applicable.

What practitioners want--and need--is more information and guidance on how to use CBD safely and effectively in clinical practice.

In this free need-to-know primer, Aimée Shunney, ND, will share 3 case studies from her practice focusing on the use of CBD to increase stress resilience, reduce anxiety, and manage depression.

From these cases, she'll draw out key clinical pearls for patient care strategies, avoidance of drug interactions, selection of products, and more.

 

VIEW WEBINAR

Learning Objectives:

  • Learn about three patients’ successful experiences using CBD for depression and anxiety
  • Explore dosing strategies and practicalities of dosing titration
  • Review known issues with cannabinoid-drug interactions
  • Discuss challenges with extreme variation in products, including full spectrum products vs isolates
  • Learn various ways to balance the endocannabinoid system
  • Gain a clear understanding of how to choose superior products

Sponsored By

CV Logo Square

Dr. Aimee Shunney HeadshotAimée Gould Shunney, ND, is a naturopathic physician in private practice since 2001, currently at Santa Cruz Integrative Medicine in Santa Cruz, CA. She combines western medical science with evidence-based natural therapies including diet, exercise, lifestyle coaching, nutritional supplements, herbal medicine, and bio-identical hormones. She specializes in women’s health and bio- identical hormone balancing as well as menopause, menstrual issues, sexual dysfunction, thyroid optimization, stress management, and digestive health.

The Roots of Supplement Quality Are in the Soil

By Kristen Schepker, Assistant Editor

For dietary supplements containing plant-derived ingredients, product quality has its roots in the soil in which those plants are grown. Recent developments in soil science and sustainable agriculture are helping conscientious companies to safeguard product quality in an era of widespread environmental degradation.

Encapsulating Quality: How Ingredient and Capsule Choices Impact Supplement Performance

By Barri Sigvertsen, Senior Manager, Global Innovation Marketing, Lonza Consumer Health and Nutrition

One of the many challenges for supplement manufacturers is consistently ensuring that the products they bring to market are safe, innovative, and aligned with practitioner and consumer preferences, while optimizing production efficiency, productivity, and profitability.

That’s no easy feat. From the choice of bioactive ingredients, through the encapsulation or tableting process, and ultimately to the packaging and shipping, there are dozens of decisions to be made. Each choice has a potential impact on overall product quality, stability, and efficacy.

Validation Testing: Insights from Inside the Analytical Lab

By Sarah M. Gannon, Analytical Chemist & Lab Manager, Designs for Health

From the outside looking in, the dietary supplement world can seem like a bewildering place. Many people wonder, “How are all these formulas blended and manufactured? How are the quality and potency being verified?” Sarah Gannon, an analytical chemist at Designs for Health pulls back the curtain.

How Practitioners Define Dietary Supplement Quality

By Erik Goldman, Editor in Chief

Product quality is a high priority for dietary supplement users, and manufacturers are well aware of that fact. Supplement makers have their own ideas about what constitutes "high quality." But as more healthcare professionals bring supplements into clinical practice, the question of how practitioners define quality becomes increasingly important. Holistic Primary Care’s 2019 practitioner survey gave us some insight.

Quality Assurance for Hemp CBD: Key Questions to Ask

By Erik Goldman, Editor in Chief

Quality assurance is a challenge for all herbal companies. For those making hemp extracts, the challenges are compounded by a confusing regulatory landscape, the inherent complexity of the plant, the surging consumer demand for CBD, and the entrance of dozens of upstart brands with no prior herbal experience and little understanding of basic QA methods.

Regulatory Confusion Reigns As FDA Grapples With CBD

By Erik Goldman, Editor in Chief

On July 30, former FDA Commissioner, Scott Gottlieb, published an op/ed in the Washington Post saying that the agency needs to get a grip on the "out of hand" CBD craze. But it's a tall order. In many ways, CBD epitomizes all the conflicting motives and scientific ambiguities with which the FDA must constantly contend.

Envisioning the Future of Dietary Supplement Regulation

By Erik Goldman, Editor in Chief

In the 25 years since Congress passed the Dietary Supplement Health and Education Act (DSHEA), the supplement industry has grown from cottage industry to multi-billion dollar global business. Rapid growth, the introduction of new ingredients, the globalization of the raw materials supply chain, the widespread use of genetically-modified ingredients, and the growing threat of economically-motivated product adulteration are  challenging DSHEA in ways its original framers could not have envisioned.

Florida Mandates Discussion of Opioid Alternatives--But Not Supplements

By Kristen Schepker, Assistant Editor

A new Florida law requires that health professionals provide chronic pain patients with information about opioid-free alternatives to pharmaceutical painkillers. The law aims to protect patients––but it's also spurring confusion among the practitioners and physicians' organizations attempting to comply.